1Gibbs MB, English JC, Zirwas MJ. Livedo reticularis:an update [J]. J Am Acad Dermatol, 2005, 52(6): 1009-1019.
2Voilum DI, Parkes JD, Doyle D. Livedo reticularis during aman- tadine treatment[J]. Br Med J, 1971, 2(5762): 627-628.
3Hayes BB, Cook-Norris RH, Miller JL, et al. Amantadine-in- duced livedo reticularis: a report of two cases[J]. J Drugs Der- matol, 2006, 5(3): 288-289.
4Rana AQ, Masroor MS. Patient perception of levido reticularis due to amantadine[J]. Int J Neurosci, 2012, 122(7): 363-366.
5Singer C, Papapetropoulos S, Gonzalez MA, et al. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series[J]. Mov Disord, 2005, 20(7): 873-877.
6Shealy C, Weeth JB, Mercier D. Livedo reticularis in patients with parkinsonism receiving amantadine[J]. JAMA, 1970, 212(9): 1522-1523.
7Sladden M J, Nieolaou N, Johnston GA, et al. Livedo retieularis induced by amantadine[J]. Br J Dermatol, 2003, 149(3): 656-658.
8Shulman LM, Minagar A, Sharma K, et al. Amantadine-indueed peripheral neuropathy[J]. Neurology, 1999, 53(8): 1862-1862.
9Minutilli E, Pompili M, Pelecea G, et al. Amantadine-in- duced livedo reticularis occurring during treatment of chronic hepatitis C[J]. J Eur Acad Dermatol Venereol, 2008, 22(11): 1368-1370.
10Xu LY, Liu A, Kerr HA. Livedo reticularis from amantadine[J]. Skinmed, 2011, 9(5): 320-321.
